Sarepta Therapeutics (SRPT) EBT Margin (2012 - 2026)
Sarepta Therapeutics' quarterly EBT Margin came in at 85.73% in Q1 2026, up 37337.0% year-on-year from N/an in Q1 2025, and up 236.45% quarter-over-quarter from 62.83% in Q4 2025.
Sarepta Therapeutics has reported EBT Margin for 13 years, with the latest figure at 85.73% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 37337.0% year-over-year to 85.73%; the trailing twelve-month figure through Mar 2026 stood at 1.32% (up 1712.0% YoY), and the FY2025 full-year result was 31.94%, down 4081.0% from the prior year.
- EBT Margin for Q1 2026 stood at 85.73%, up from 62.83% in the prior quarter.
- The five-year high for EBT Margin was 199.35% in Q4 2022, with the low at 473.28% in Q1 2022.
- Average EBT Margin over 5 years is 57.53%, with a median of 10.0% recorded in 2023.
- Year-over-year, EBT Margin plunged 35936 bps in 2022 and jumped 37337 bps in 2026.
- Tracing SRPT's EBT Margin over 5 years: stood at 199.35% in 2022, then tumbled by 70 bps to 60.2% in 2023, then slumped by 80 bps to 12.1% in 2024, then plunged by 619 bps to 62.83% in 2025, then soared by 236 bps to 85.73% in 2026.
- The last three EBT Margin figures came in at 85.73% (Q1 2026), 62.83% (Q4 2025), and 48.59% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 85.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.73% |
| Dec 31, 2025 | -62.83% |
| Sep 30, 2025 | -48.59% |
| Jun 30, 2025 | 25.14% |
| Mar 31, 2025 | -287.64% |
| Dec 31, 2024 | 12.10% |
| Sep 30, 2024 | 7.28% |
| Jun 30, 2024 | 3.74% |
| Mar 31, 2024 | 10.02% |
| Dec 31, 2023 | 60.20% |
| Sep 30, 2023 | -10.00% |
| Jun 30, 2023 | -65.55% |
| Mar 31, 2023 | -202.25% |
| Dec 31, 2022 | 199.35% |
| Sep 30, 2022 | -123.41% |
| Jun 30, 2022 | -108.00% |
| Mar 31, 2022 | -473.28% |
| Dec 31, 2021 | -66.31% |
| Sep 30, 2021 | -25.29% |
| Jun 30, 2021 | -57.64% |
| Mar 31, 2021 | -113.93% |
| Dec 31, 2020 | -837.93% |
| Sep 30, 2020 | -873.10% |
| Jun 30, 2020 | -579.58% |
| Mar 31, 2020 | -131.39% |
| Dec 31, 2019 | -234.73% |
| Sep 30, 2019 | -127.32% |
| Jun 30, 2019 | -291.79% |
| Mar 31, 2019 | -87.99% |
| Dec 31, 2018 | -167.83% |
| Sep 30, 2018 | -98.19% |
| Jun 30, 2018 | -147.76% |
| Mar 31, 2018 | -54.52% |
| Dec 31, 2017 | -45.11% |
| Sep 30, 2017 | -99.50% |
| Jun 30, 2017 | -180.39% |
| Mar 31, 2017 | 526.80% |
| Dec 31, 2014 | -165,637.04% |
| Sep 30, 2014 | -3,179.89% |
| Jun 30, 2014 | -1,171.93% |
| Mar 31, 2014 | -412.63% |
| Dec 31, 2013 | -1,250.91% |
| Sep 30, 2013 | -596.69% |
| Jun 30, 2013 | -579.67% |
| Mar 31, 2013 | -339.25% |
| Dec 31, 2012 | -140.17% |
| Sep 30, 2012 | -90.28% |
| Jun 30, 2012 | -48.63% |
| Mar 31, 2012 | -60.45% |